JP3532817B2 - Method for producing marine organism-derived collagen - Google Patents

Method for producing marine organism-derived collagen

Info

Publication number
JP3532817B2
JP3532817B2 JP2000014283A JP2000014283A JP3532817B2 JP 3532817 B2 JP3532817 B2 JP 3532817B2 JP 2000014283 A JP2000014283 A JP 2000014283A JP 2000014283 A JP2000014283 A JP 2000014283A JP 3532817 B2 JP3532817 B2 JP 3532817B2
Authority
JP
Japan
Prior art keywords
membrane
collagen
purification
purified
collagen solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2000014283A
Other languages
Japanese (ja)
Other versions
JP2001200000A (en
Inventor
健知 鹿原
聡 宮崎
美奈 岡村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Air Water Inc
Original Assignee
Air Water Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Air Water Inc filed Critical Air Water Inc
Priority to JP2000014283A priority Critical patent/JP3532817B2/en
Publication of JP2001200000A publication Critical patent/JP2001200000A/en
Application granted granted Critical
Publication of JP3532817B2 publication Critical patent/JP3532817B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明海洋生物の皮膚を原
各種の医療用生体材料化粧品材料食品材料
などこれらに有用酸可溶性コラーゲン量産するため
製造方法に関する。
The present invention relates to a variety of medical biomaterials, cosmetics, materials and food material to the skin of marine life in the raw material BACKGROUND OF THE INVENTION
Such as to mass-produce useful acid-soluble collagen thereto
A method for manufacturing.

【0002】[0002]

【従来の技術】上記の分野で用いられるコラーゲンは主
牛や豚などほ乳類の皮膚を原料として抽出されてい
る。近年はほ乳類だけでなく産業廃棄物であるところ
海洋生物の皮膚からもコラーゲンを抽出製造するとい
研究が行われている。
BACKGROUND OF THE INVENTION Collagen used in the above fields is mainly
The mammalian skin such as cattle and pigs have been extracted as a raw material in
It In recent years, as well as mammals, where it is industrial waste
The collagen extraction production Then Some from marine organisms of the skin of the
Cormorant research has been carried out.

【0003】ラーゲンの製造方法で用いられるほ乳類
の皮膚が図6に示されている。図6を参照してほ乳類の
皮膚層表皮層a真皮層b皮下層cからなる。この
皮膚層は表皮層aから真皮層bまでが5〜7mm程度と
かなりい。そのうちでコラーゲンは真皮層bに含ま
れ、色素などの不純物は表皮層a含まれている。した
がって色素細胞dも表皮層a側にある。このようなほ
皮膚にあっては、抽出工程に先行する前処理工程での
切離手段により、色素などを含む表皮層aを比較的厚
皮膚か物理的除去する。これは後述海洋生物を原
料とするものと較した場合に、素などの混入がほと
んどないコラーゲン溶液がられるということである。
抽出工程で得られたコラーゲン溶液遠心分離装置にか
られて不純物がさらに除去されたのち、滅菌ろ過工程
を経る。かくてコラーゲン製造される。このときには
遠心分離装置とし大型ものが入手できるから一度に
大量のコラーゲンを精製することができ、それがコラー
ゲンの量産化に通じる。
[0003] The mammal to be used in the production method of collagen
Skin is shown in FIG. Referring to FIG. 6, the skin layer of mammals is composed of an epidermis layer a , a dermis layer b, and a subcutaneous layer c. this
The skin layer is about 5 to 7 mm from the epidermis layer a to the dermis layer b.
Rather not thickness. Among them, collagen is contained in the dermal layer b
Is, impurities such as dyes are contained in the skin layer a. did
Therefore, the pigment cell d is also on the epidermal layer a side. In the this Yonaho milk <br/> such skin, in the pretreatment step preceding the extraction step
The separating means, relatively thick have <br/> skin or al physically removing the skin layer a containing and color elements. This is the original marine life below
When the comparison that the charge is that the collagen solution mixed absence etc. N photo <br/> such as color element is obtained.
Collagen solution obtained in the extraction process after an applied and impurities are further removed in the centrifugal separator, Ru through sterile filtration step. Thus collagen is produced . Since a large size this sometimes as a <br/> centrifugal separator are available can be purified a large amount of collagen at a time, it leads to mass production of Koller <br/> Gen.

【0004】一方で海洋生物からのコラーゲン製造手段
研究途上にある。これについては後述の方法小規模
に試行されている。
On the other hand, means for producing collagen from marine organisms
Is in the process of being researched . The method described below for this is that has been tried on a small scale.

【0005】海洋生物からのコラーゲン製造で用いられ
などについてはつぎのとおりである。皮膚層は前記
三層である。しかし皮下層cを除く表皮層aから
真皮層b間までの厚さは図7のとおり約1〜2mm
く、その薄い真皮層bにコラーゲン含まれている。
かも真皮層bの上層部位に存在する色素細胞dなどの不
純物は、ほ乳類べた場合に量が多い。したがって
など海洋生物の場合は、皮膚層が薄いという理由で、
などを含んだ部分だけ除去するの困難になる
Used in the production of collagen from marine organisms
The salmon etc. are as follows. The skin layer is the above
It is the same three-layer with. But the thickness of the skin layer a except subcutaneous layer c to between the dermal layer b are as about 1~2mm and thin <br/> rather in Figure 7, contains a collagen in its thin dermal layer b. Moreover, pigment cells d and the like existing in the upper layer portion of the dermis layer b
Neat, the greater the amount if mammals and specific solid. Therefore salmon
For marine life such as the reason that the skin layer is thin, it is difficult to remove only the part containing such dyes.

【0006】そのため鮭など海洋生物からのコラーゲン
製造手段では、前処理工程のときにつぎのようにする。
鮭皮については図7のウロコ(鱗)e・ヒレ(鰭)
などを除去する程度とする。この鮭皮を図8のように
したり脂質抽出したりしてから洗浄する。うして
得られた処理済サンプルについては、既知のとおり、
機酸処理してコラーゲンを抽出すると同時にペプシン
などを加えてアテロ化するか、または、図8のように
出処理後に遠心分離装置にかけ、それからアテロ化処理
を行うなど、何れかの方法を選択して二度目の抽出工程
を実施する。このコラーゲン抽出溶液中には色素など
の不純物微粒子となって多数存在する。しかもこの微
粒子非常に軽く、上記抽出工程での通常の遠心分離処
沈殿しないため十分に除去することができない。
の対策として、上記抽出工程で得られた粗コラーゲンを
つぎの精製工程において塩析・遠心分離・超遠心分離な
どにかける。精製工程のはじめは塩析と遠心分離とを繰
り返す。すなわち塩析で得た沈殿を遠心分離で回収し
ペプシンの除去と不純物の除去とを行い、これに酢酸
を加えて酸可溶性コラーゲンを得る。ついでこれを超遠
心分離装置にかけてその上清を回収するこの後は図8
最終滅菌ろ過工程移行する。この滅菌ろ過工程の
ときは、前工程回収した上清濃縮液をろ過滅菌膜に通
して滅菌ろ過し、それから透過液を脱イオン水により透
析するか、または、透析を先行させてから滅菌ろ過を行
うようにし、その後凍結乾燥することで酵素可溶性コ
ラーゲンを得
Therefore, collagen from marine organisms such as salmon
The manufacturing means performs the following in the pretreatment process .
For salmon skin, scale (e) , body, and fin ( fin) of Fig. 7
The extent to which and the like are removed. Washing the salmon skin from or extracted lipids or shredded as in FIG. For this Ushite <br/> obtained treated samples, as is known, either Atero of it like is added simultaneously pepsin when extracting the collagen is treated with an organic acid, or extraction as in FIG. 8 < After the extraction treatment, the second extraction step is carried out by selecting one of the methods such as applying a centrifuge and then performing an atherogenic treatment. Impurities <br/> such crude collagen extraction solution in the dye are present many become fine particles. Moreover, since these fine particles are very light and do not precipitate by the usual centrifugal separation treatment in the above extraction step , they cannot be sufficiently removed. So
As a measure against the crude collagen obtained in the above extraction process
Do not salt out, centrifuge, or ultracentrifuge in the next purification step .
Hang on. At the beginning of the purification process, salting out and centrifugation are repeated . That precipitate obtained in salting was collected by centrifugation
Perform the removal and removal of impurities pepsin Te, to which Ru to give the acid soluble collagen with acetic acid. This was then recovering the supernatant subjected ultracentrifuge. Figure 8 after this
In moves to final sterile filtration step. Of this sterile filtration process
Time, before the collected supernatant concentrate sterile filtered through sterile filtration membranes in step, either dialysis permeate with deionized water therefrom, or to carry out the sterilization filtration by prior dialysis, Thereafter, Ru give enzyme soluble collagen by lyophilization.

【0007】[0007]

【発明が解決しようとする課題】洋生物由来コラーゲ
ンの製造方法によるときは上記のとおり、精製工程で塩
析や遠心分離を行う。しかし遠心分離を繰り返すだけの
とき、かなりの時間をかけたとしても多数存在する不純
物(軽い微粒子)が除去しきれず、その後に超遠心分離
相当(100000×G)の遠心力を与えて微粒子を沈
殿除去しなければならない。その一方で一度に大量精製
能な超遠心分離装置がないため、一回あたり精製でき
るコラーゲンの量が400cc程度に抑えられる。もち
ろん量産規模に見合う台数を揃える場合には巨額の設備
投資が強いられる。魚皮から色素など不純物を除去
すること困難性ゆえ、無色色素の魚皮とくにフラット
フィッシュの皮からコラーゲンの抽出を行う内容の製造
方法(特許第2722014号)提案されたりしてい
る。
As described above when due to manufacturing method of marine biological collagen [0005], intends row salting and centrifuged at purification step. But just repeat the centrifugation
When not completely significant impurities present many as over time (light particle) is removed, precipitated particulates then giving centrifugal force ultracentrifugation equivalent (10 00 00 × G)
It must be removed by Shingarijo. On the other hand large amount purified at a time
Since there is no possible ultracentrifugation apparatus, the amount of collagen can be purified per operation is suppressed to about 400 cc. Rice cake
Of course , a huge amount of capital investment will be required to match the number of units to the mass production scale . Difficulty because of the removal of impurities such as dye from this fish skin, the manufacturing method of the content to extract collagen from fish skin, especially flat fish skin colorless dye (Japanese Patent No. 2722014) is or is proposed .

【0008】本願発明上記従来技術の課題に鑑み
れたものであり、つぎのようなことを目的とする。 (1) 精製工程については既成工程のような遠心分離・塩
析・超遠心分離処理でなく精製ろ過処理とし、その後に
濃縮処理による濃縮工程を設定する。こうすることで超
遠心分離装置を用いることのない微粒子除去を可能にし
たり、コラーゲン濃縮と共にペプシンなどの不純物除去
を可能にしたりする。 (2) 精製工程での精製ろ過処理により、抽出工程で得ら
れる粗コラーゲン溶液からの連続的な不純物除去や必要
生産規模に応じたコラーゲン大量精製を可能にする。こ
れはコラーゲン大量精製の際の巨額の設備投資を回避す
ることに通じる。 (3) 製造日程について大幅な短縮をはかる一方、製造面
からは閉鎖的な製造ラインの採択を可能にして外部汚染
の心配をなくし衛生上安心できるようにする。かくて産
業廃棄物とされていた海洋生物の皮膚から安価なコラー
ゲンを医療関係・化粧関係・食品関係に提供できるよう
にする。 (4) 抽出工程からの粗コラーゲン溶液から不溶物を除去
するための精製工程において、精製膜の膜サイズを1.
0μm未満〜0.1μmとすることにより、コラーゲン
の回収率を低下させずに、かつ、色素の微粒子除去効率
も低下させずに、より望ましい精製効果を発揮させる。 (5) 精製ろ過工程から精製コラーゲン溶液の分子量分画
以下の不純物を除去するための濃縮工程において、濃縮
用膜の膜サイズを1000K未満〜10Kの限界ろ過膜
とすることにより、ペプシンなど不純物除去率の低下や
コラーゲン回収率の低下を回避して、より望ましい濃縮
効果をあげる。 (6) 精製膜の膜サイズを0.2μm〜0.6μmにした
り濃縮用膜の膜サイズを10K〜100Kにしたりする
ことで精製効果と濃縮効果をさらに高める。 (7) 各溶液(粗コラーゲン溶液・精製コラーゲン溶液・
濃縮コラーゲン溶液など)がそれぞれの膜(精製膜・濃
縮用膜など)に対してその流れ方向と直交するように透
過させるようにする。こうすることで不純物が膜表面に
堆積することを排除して目詰まりの生じないようにし
り、最終的に得られる酵素可溶コラーゲンの純度より
向上させたりする。 (8) 抽出で得られた粗コラーゲン溶液から不溶物を除去
してそれを精製膜通過させるという精製ろ過で不純物を
除去しそれをアテロ化する。このように遠心分離による
ことなく精製ろ過処理することでその後の精製工程にお
ける不純物の除去をより行い易くする。
[0008] The present invention has been name of <br/> is view of the problems of the prior art, and an object thereof as follows. (1) Centrifuge / salt as in the existing process for the purification process
Purification and filtration instead of precipitation and ultracentrifugation, and then
The concentration process by the concentration process is set. Super by doing this
Enables fine particle removal without using a centrifuge
Or removing impurities such as pepsin along with collagen concentration
To enable. (2) Obtained in the extraction process by the purification filtration process in the purification process.
Continuous removal of impurities from the crude collagen solution
Enables large-scale purification of collagen according to production scale. This
This avoids huge capital investment in the mass purification of collagen
Understand. (3) The manufacturing schedule is significantly shortened, while the manufacturing aspect
To allow the adoption of a closed manufacturing line and external pollution
To eliminate the worry of and to be relieved in hygiene. Produced
Cheap Coller from the skin of marine life that was considered industrial waste
To be able to provide Gen to medical-related, makeup-related, and food-related
To (4) Remove insoluble matter from crude collagen solution from extraction process
In the purification step to
Collagen of less than 0 μm to 0.1 μm
Efficiency of dye removal without lowering the recovery rate of dyes
It also exerts a more desirable purification effect without lowering. (5) Molecular weight fractionation of purified collagen solution from purification filtration step
In the concentration process to remove the following impurities,
Ultrafiltration membrane with a membrane size of less than 1000K-10K
This reduces the removal rate of impurities such as pepsin and
More desirable concentration by avoiding a decrease in collagen recovery rate
Increase the effect. (6) The membrane size of the purified membrane was 0.2 μm to 0.6 μm
The size of the concentrating membrane to 10K-100K
This further enhances the purification effect and the concentration effect. (7) Each solution (crude collagen solution, purified collagen solution,
Concentrated collagen solution, etc. is used for each membrane (purified membrane / concentrated
Permeation membrane (for example, a compressive membrane) so that the permeation is perpendicular to the flow direction . By doing so, impurities were prevented from accumulating on the film surface and clogging did not occur .
Ri, the purity of the finally obtained enzyme soluble collagen or further improved. (8) Remove insoluble matter from crude collagen solution obtained by extraction
Then, purify it through a purification membrane to remove impurities.
Remove and atheroize it. Thus by centrifugation
By performing the purification filtration process without
It is easier to remove impurities.

【0009】[0009]

【課題を解決するための手段】本発明請求項1に係る
海洋生物由来コラーゲンの製造方法は所期の目的を達成
するために下記の課題解決手段を特徴とする。すなわち
請求項1に記載の当該製造方法は、海洋生物の皮膚を脱
脂した後これを洗浄して処理済サンプルを得る前処理工
程と、この処理済サンプルに有機酸を加えてコラーゲン
を抽出するとともこれに蛋白質分解酵素を加えてアテ
ロ化することにより粗コラーゲン溶液を抽出する抽出工
程と、この粗コラーゲン溶液から不溶物を除去したもの
精製膜で精製するとき当該粗コラーゲン溶液がその流
れ方向と直交する方向に精製膜を透過していくようにす
精製工程と、これにより得られた精製コラーゲン溶液
を濃縮用膜濃縮し分子量分画以下の不純物を除去す
とき当該精製コラーゲン溶液がその流れ方向と直交す
る方向に濃縮用膜を透過していくようにする濃縮工程
と、これにより得られた濃縮コラーゲン溶液滅菌ガス
加圧してろ過滅菌膜を通過させる滅菌ろ過処理または
当該濃縮コラーゲン溶液を透析する透析処理のうち何れ
かを先行させてこれらの処理を行うことにより滅菌ろ過
後サンプルを回収する滅菌ろ過工程とからなることを特
徴とする。
According to a first aspect of the present invention, in order to solve the problems]
A method for producing collagen derived from marine organisms achieves the intended purpose
In order to achieve this, the following means for solving the problems are featured. Ie
The process according to claim 1 includes a pretreatment step of obtaining a washed and treated samples this was degreased skin marine organisms, to together when extracting collagen with an organic acid added to the treated sample an extraction step of extracting the crude collagen solution by Atero by addition of proteolytic enzymes thereto, obtained by removing insolubles from the crude collagen solution
When the crude collagen solution is purified with a purification membrane ,
Permeation through the purification membrane in the direction orthogonal to
A purification step that, to perpendicular to the purified collagen solution is its flow direction when the thus obtained purified collagen solution was concentrated concentrating membrane to remove molecular weight fraction or less impurities
A concentration step to go through the concentrating layer in the direction that, the sterilizing gas concentrated collagen solution thereby obtained
Sterile filtration or in pressurized passing sterile filtration membranes
It is characterized by comprising a sterilizing filtration step of collecting a sample after sterilizing filtration by performing these treatments in advance of any one of dialysis treatments for dialysis of the concentrated collagen solution .

【0010】本発明の請求項2に係る海洋生物由来コラ
ーゲンの製造方法は所期の目的を達成するために下記の
課題解決手段を特徴とする。すなわち請求項2に記載の
当該製造方法は、海洋生物の皮膚を脱脂した後これを
浄して処理済サンプルを得る前処理工程と、この処理済
サンプルに有機酸を加えてコラーゲンを抽出した粗コラ
ーゲン溶液から不溶物を除去したりそれを精製膜
精製ろ過したりさらにそれに蛋白質分解酵素を加えて
アテロ化したりする抽出工程と、これにより得られた第
1精製コラーゲン溶液を精製膜で精製するとき当該第1
精製コラーゲン溶液がその流れ方向と直交する方向に精
製膜を透過していくようにする精製工程と、これにより
得られた第2精製コラーゲン溶液を濃縮用膜で濃縮して
分子量分画以下の不純物を除去するとき第2精製コラー
ゲン溶液がその流れ方向と直交する方向に濃縮用膜を透
過していくようにする濃縮工程と、これにより得られた
濃縮コラーゲン溶液滅菌ガス加圧してろ過滅菌膜を
通過させる滅菌ろ過処理または当該濃縮コラーゲン溶液
を透析する透析処理のうち何れかを先行させてこれらの
処理を行うことにより滅菌ろ過後サンプルを回収する滅
菌ろ過工程とからなることを特徴とする。
Coral derived from marine organisms according to claim 2 of the present invention
In order to achieve the intended purpose,
It is characterized by a problem solving means. That is, according to claim 2.
The manufacturing method includes a pretreatment step of degreasing the skin of marine organisms and then washing the same to obtain a treated sample, and a crude collagen solution in which collagen is extracted by adding an organic acid to the treated sample. it or to remove insoluble material was passed in purified membrane from
An extraction step or to Atero by addition of further proteolytic enzyme to it or purified filtered Te, the first time the purification of the first purified collagen solution thereby obtained in purified membrane
The purified collagen solution is refined in a direction orthogonal to its flow direction.
A purification step to make go through the film, the second purified Koller when removing the second purified collagen solution concentrated membrane with concentrated by <br/> molecular weight fractionation following impurities thereby obtained
The gen solution passes through the concentration membrane in a direction orthogonal to its flow direction.
A concentration step to go spent, sterile filtration or the concentrate collagen solution is passed through a sterile filtration membrane thus obtained was concentrated collagen solution is pressurized with sterile gas
These are preceded by any of the dialysis treatments
It is characterized by comprising a sterilization filtration step of collecting a sample after sterilization filtration by performing a treatment .

【0011】本発明の請求項3に係る海洋生物由来コラ
ーゲンの製造方法は、請求項1または2記載の方法にお
いて、精製工程における精製膜が膜サイズ1.0μm未
満〜0.1μmのものであり、濃縮工程における濃縮用
膜が膜サイズ1000K未満〜10Kの限外ろ過膜であ
ることを特徴とする
[0011] According to claim 3 of the present invention, the marine organism-derived cola
The method for producing a gene is the method according to claim 1 or 2.
The purification membrane in the purification step has a membrane size of less than 1.0 μm to 0.1 μm , and the concentration membrane in the concentration step is an ultrafiltration membrane having a membrane size of less than 1000K to 10K.
It is characterized by

【0012】本発明の請求項4に係る海洋生物由来コラ
ーゲンの製造方法は、請求 項1〜3いずれかに記載の方
法において、精製工程における精製膜が膜サイズ0.2
μm〜0.65μmのものであり、濃縮工程における
縮用膜が膜サイズ10K〜100Kのものであることを
特徴とする。
[0012] A marine organism-derived cola according to claim 4 of the present invention.
The method for producing a gene according to any one of claims 1 to 3.
In law, purified membrane film size in the purification step 0.2
μm~0.65μm are those of the concentrated <br/> reduced membrane in the concentration step is of film size 10K~100K
Characterize.

【0013】[0013]

【発明の実施の形態】本発明に係る海洋生物由来コラー
ゲンの製造方法で図1図2図4図5に例示された
ものは、前処理工程抽出工程精製工程と濃縮工程
滅菌ろ過工程とからなる。
BEST MODE FOR CARRYING OUT THE INVENTION Marine organism-derived coller according to the present invention
Illustrated in Figure 1, Figure 2 and FIGS. 4 and 5 in Gen manufacturing method
The product comprises a pretreatment step , an extraction step , a purification step, a concentration step, and a sterile filtration step.

【0014】図1を参照して前処理工程はつぎのような
ものである。鮭皮など魚皮については流水中で身などの
不要部を除去して3cm角程度に細断する。このミンチ
済魚皮をたとえばクロロホルムとメタノールの混合溶液
に投入して攪拌する。さらにいえば当該溶媒を交換して
攪拌を繰り返す。その後、メタノールに置換したり脱イ
オン水に置換したりしてミンチ済魚皮を洗浄した後、さ
らに20%NaClを含んだ緩衝溶液等による洗浄
イオン水による洗浄を洗浄液交換のもとで繰り返して中
性蛋白質を除去する。かくて図1に示す処理済サンプル
られる
Referring to FIG . 1, the pretreatment process is as follows.
It is a thing. For fish skins such as salmon skin, remove unnecessary parts such as the body in running water and shred into 3 cm squares . This minced
If example Tato the already fish skin and stirred was put in a mixed solution of chloroform and methanol. Further to repeat the stirring and replace the solvent speaking. As after the original by or replaced with deionized water or substituted in methanol after washing the minced already fish skins, further cleaning liquid exchange washing with cleaning and deionized water by a buffer solution such as a solution containing 20% NaCl to remove the neutral protein repeatedly with. Thus the processed sample shown in Figure 1
It is obtained.

【0015】図1を参照して抽出工程のときは、図2
例示された製造装置抽出タンク1a1bに処理済サ
ンプルを投入し、これに5M酢酸と対基質重量
の1%のペプシンまたはその他の蛋白質分解酵素を加
え、これらを攪拌することアテロ化を行う。このよう
に、有機酸によるコラーゲンの抽出と同時にアテロ化
粗コラーゲン溶液を得る場合は、抽出されるコラーゲ
ンの量が増加する利点があるものの、同時に色素等の不
純物も大量に溶液中へ混入してくることになる
[0015] When the extraction step with reference to Figure 1, Figure 2
The processed tanks are added to the extraction tanks 1a and 1b of the exemplified manufacturing equipment.
Sample was charged, this to 0. And 5M acetic acid, and 1% pepsin or other proteolytic enzymes to substrate weight was added, perform Atero reduction by stirring them. like this
To, and Atero simultaneously with extraction of collagen with an organic acid
To obtain a crude collagen solution Te, while the amount of collagen that is extracted is the advantage of increasing, so that the coming mixed into simultaneously impurities mass in solution, such as a dye.

【0016】したがって上記で得られ粗コラーゲンS
1は、ナイロンメッシュなど不溶物を除去した後、図
2のポンプ2a2bを稼動させることによりサンプル
タンク3に移し、それから新規精製工程にかける。す
なわちサンプルタンク3の粗コラーゲンS1について
流速をポンプ3a3bで制御しつつ精製膜4に通し、
の膜通過で得られ精製コラーゲン溶液S2精製・
濃縮タンク5に移送する。図示例の場合、精製膜4によ
って通過を阻止された残留物などはサンプル循環流路6
を介しサンプタンク3に戻。またコラーゲンの回
収量増量はかるため、酢酸等による溶媒をポンプ9の
作動で溶媒添加用タンク7→溶媒添加流路8→サンプル
タンク3のように流動させ、当該タンク3添加する
これで上記残留物などに含まれるコラーゲン分子さら
に回収される
[0016] Thus crude collagen S that obtained in the above
1, after removal of the insoluble matter such as nylon mesh, transferred to a sample tank 3 by operating the pump 2a · 2b in FIG. 2, subjected then to a novel purification process. You
The crude collagen S1 of ie sample tank 3 through the purified membrane 4 while controlling the flow rate of a pump 3a · 3b,
Purified is that purified collagen solution S2 obtained in the film passage of this -
Transfer to the concentration tank 5 . In the case of the example shown in the drawing, the sample circulation channel 6 is used to remove the residue and the like blocked by the purification membrane 4.
Ru return to the sump tank 3 via the. Further, since the measure recovery amount increasing collagen, the solvent with acetic acid or the like of the pump 9
Solvent addition tank 7 by operation → solvent addition flow path 8 → sample
It is made to flow like the tank 3 and added to the tank 3 .
This collagen molecules contained in such the residue is recovered in further <br/>.

【0017】つぎの濃縮工程についていうと、図2の精
製・濃縮タンク5に入った精製コラーゲン溶液S2は、
ポンプ10で流速などを制御されながら濃縮用膜11を
通過し、その後、サンプル循環流路12を経由して精製
・濃縮タンク5に戻るということで濃縮される。この際
生じた不溶物は溶媒と共に排水流路13から廃液タン
ク14へ排出される。かかる濃縮工程によって、液量の
増えた精製コラーゲン溶液S2の濃縮と、分子量分画以
下の不純物の除去がなされ、それで濃縮コラーゲン溶
液S3られる。
[0017] With respect to the next concentration step, purified collagen solution S2, which enters the purification and concentration tank 5 in FIG. 2,
It is concentrated by passing through the concentration membrane 11 while controlling the flow rate and the like by the pump 10, and then returning to the purification / concentration tank 5 via the sample circulation channel 12. On this occasion
Insoluble matter occurs in the Ru is discharged from the drain passage 13 together with the solvent into the waste tank 14. With such a concentration step, the concentration of purified collagen solution S2, which increases the liquid volume, removal of the molecular weight fraction below impurities and is made, it is Ru obtained concentrated collagen solution S3.

【0018】菌ろ過工程図1に示されているとお
り、従来のそれと実質的に同じ内容である。これは図2
精製・濃縮タンク5内にある濃縮コラーゲン溶液S3
ポンプ15の作動で精製・濃縮タンク5→濃縮サンプ
ル流路16ろ過滅菌用タンク17のように流動させ
る。精製・濃縮タンク5内にある濃縮コラーゲン溶液S
3を全量送り出したならば、滅菌空気とか滅菌窒素ガス
とかの加圧ガス19を加圧用気体流路18からろ過滅菌
用タンク17内に送り込み、該タンク17内から流出す
る濃縮コラーゲン溶液S3をたとえば膜サイズ0.22
μmのろ過滅菌膜20に通す。この膜通過後のろ過滅菌
後サンプルS4を製品として回収するか、または、これ
を凍結乾燥機21に送って製品とする。かくて酵素可溶
コラーゲンが得られる。この間は、全工程にわたって温
度制御を行い10℃以下好ましくは4℃〜5℃程度に保
持するのがよい。これは蛋白質の変性を防止するため
行う。
The sterilization filtration step is shown in Figure 1 the far
Ri, Ru conventional substantially the same as the contents Der. This is Figure 2
Concentrated collagen solution S3, in the purification and concentration tank 5
By operating the pump 15 so that the purification / concentration tank 5 → concentrated sample flow path 16 filtration sterilization tank 17 flow
It Concentrated collagen solution S in the purification / concentration tank 5
When all 3 has been sent out , the sterilized air or sterilized nitrogen gas, which is a pressurized gas 19, is sterilized by filtration from the gas passage 18 for pressurization.
It is sent into the tank 17 for use and flows out from the inside of the tank 17.
A concentrated collagen solution S3 with a membrane size of 0.22
It is passed through a filter sterilization membrane 20 of μm . Filter sterilization after passing through this membrane
The post sample S4 is collected as a product or is sent to the freeze dryer 21 to be a product . Thus by the enzyme soluble collagen Ru obtained. During this time, temperature control is performed throughout the entire process, and it is preferable to maintain the temperature at 10 ° C. or lower, preferably at 4 ° C. to 5 ° C. This is in order to prevent denaturation of proteins
To do.

【0019】精製工程についていうと、あらかじめ、
製膜4の洗浄フラッシング初期清水透過流速の確認
を行い、フラッシング後、必要があればバッファーなど
で系内を最適化するのがよい。また原液に対して
宜、溶媒などを加水するが望ましい。さらに経時的に
圧力や温度を設定したり、十分量の透過液が得られたと
ポンプ3bを停止したり、透過側系内の清澄液を極力
回収したりする。濃縮手順についても上記と同様、濃縮
用膜11洗浄フラッシング初期清水透過流速の確
必要バッファーなどで系内を最適化するのがよ
い。濃縮については必要に応じた濃縮倍率で行うのがよ
い。
Regarding the purification step, it is necessary to confirm the washing / flushing / initial fresh water permeation flow rate of the purification membrane 4 in advance, and after flushing, optimize the system with a buffer etc. if necessary. Good. In addition, suitable for the stock solution
Yichun, is to hydrolysis and solvent not desirable. In addition , the pressure and temperature were set over time, and a sufficient amount of permeate was obtained .
Or stop can pump 3b, or the clarified liquid in the permeation side system as much as possible collected. Like the above for enrichment procedure, it is to optimize the system, such as the confirmation-required buffer wash flushing initial Shimizu permeation rate of the concentration membrane 11
Yes. It may be carried out in the concentration ratio as needed for enrichment.

【0020】出工程後精製工程用いられる精密ろ
過(MF)膜としての精製膜4や、これに続濃縮工程
で用いられる濃縮用膜11について、膜サイズを特定範
囲内に選定するときはつぎのようになる。精製膜4の膜
サイズについては、1.0μm未満〜0.1μmとする
のが好ましい。その理由は1.0μm以上の膜サイズに
すると色素の微粒子除去が困難になり、膜サイズが0.
1μmよりも小さくなるコラーゲンの回収率が低下す
からである。濃縮用膜11については、分子量分画が
1000K未満〜10Kの限外ろ過(UF)膜を使用す
るのが好ましい。その理由は1000K以上の場合
ラーゲンの回収が低下し、10Kよりも小さくなるとペ
プシンなど不純物除去率が低下するからである。
The extract or purified membrane 4 as microfiltration (MF) membrane used in the purification step after the step out, to the concentrating film 11 used Succeeding concentration step which selects a film size within a specific range The time is as follows. The membrane size of the purified membrane 4 is preferably less than 1.0 μm to 0.1 μm. The reason is that when the film size is 1.0 μm or more, it becomes difficult to remove the fine particles of the dye, and the film size is less than 0.
It becomes smaller when the collagen recovery than 1μm is lowered. As the concentration membrane 11, it is preferable to use an ultrafiltration (UF) membrane having a molecular weight fraction of less than 1000K to 10K. The reason is because decreases the recovery of co <br/> collagen in the case of more than 1000 K, the removal rate of impurities such as small comes to pepsin than 10K is decreased.

【0021】製膜4濃縮用膜11の膜サイズについ
て、さらに望ましい寸法範囲を選定するときはつぎのよ
うになる。精製膜については0.2μm〜0.65μm
にする。その理由は0.65μm以下とすること色素
の微粒子除去率が低下せず、0.2μm以上とすること
コラーゲンの回収率が低下しないからである。濃縮用
膜11については10K〜100Kの膜サイズとするこ
ペプシンなど不純物除去率低下せず、コラーゲ
ンの回収率低下しない。
[0021] attached to the membrane size of the refining film 4 and concentrated for the film 11
Te, the Hatsugi when selecting a more desirable size range
Growls 0.2 μm to 0.65 μm for purified membrane
You to. The reason is that the fine particle removal rate of the dye does not decrease when the particle size is 0.65 μm or less, and the particle size is 0.2 μm or more.
This is because the recovery rate of collagen does not decrease . It does not decrease the removal rate of impurities such as pepsin by a film size of 10K~100K for concentrating film 11, the recovery of collagen nor decrease.

【0022】製ろ過工程の精製膜4と濃縮工程の濃縮
用膜11としてはいずれもタンジェンシャル・フロー・
フィルトレーション(TFF)を用いる。ちなみに通常
多用される膜種ものは、図4のように膜F1と透過溶液
の流れ方向D1とが直交するため、当該流れ方向D1と
平行する方向に溶液が透過して透過側P1に流出する。
これに対し図5に示すTFFの場合は、粗コラーゲン溶
液S1や精製コラーゲン溶液S2などの透過溶液が、そ
れらの流れ方向D2と直交する方向精製膜4や濃縮用
膜11(一対の膜F2)を透過し、それぞれの透過側P
2・P3流出する。したがってTFFを用いるとき
は、膜F2の膜面に対する不純物等の堆積が透過溶液の
流動によって防止され、目詰りのない透過状態を保持す
ることができる。これはすなわち、精製ろ過処理と濃縮
処理とがきわめて短期日内に処理でき、コラーゲンの回
収率と色素の微粒子やペプシンなど不純物除去率と
向上するということである。
[0022] - tangential Both the concentrating layer 11 of purified membrane 4 and concentration step of refining filtration step Flow
Filtration (TFF) is used . Incidentally usually frequently used as film type ones, since the the film F1 and the permeate solution flow direction D1 as shown in FIG. 4 orthogonal, the solution in the direction parallel to the flow direction D1 flows out after passing through the permeate side P1 .
On the other hand, in the case of the TFF shown in FIG. 5, the permeation solution such as the crude collagen solution S1 and the purified collagen solution S2 is
Purification in a direction perpendicular to the those of the flow direction D2 film 4 and concentrating film 11 (the pair of film F2) passes, each of the permeate side P
It flows out to the 2 · P3. So when using TFF
It may be deposited, such as impurity with respect to the film surface of the film F2 is prevented by the flow of the permeate solution, holding the free transmission state of clogging. This means that the purification filtration process and the concentration process can be performed within an extremely short period of time, and the recovery rate of collagen and the removal rate of impurities such as pigment fine particles and pepsin are improved .

【0023】出工程に関しては図1に記載されている
とおり抽出処理とアテロ化処理が同時なく各別に
実施されることがある。これについては図3にされ
製造装置施できる。図3の製造装置は、ポンプ2
2を備えた第1精製サンプル流路23を介してサンプル
タンク3と精製・濃縮タンク5とが連通されているこ
、この点が図2のものと相違する。けれどもその他は
図2ものと実質的に同じである。したがって図3の場
合、図2と同一の部材については同一符号が付されてい
る。
[0023] In regard Extraction process as <br/> listed in Figure 1, the extraction process and Atero treatment is to be performed independently in not simultaneous. Is an example shown in Figure 3 for this
Kill in the implementation in the manufacturing equipment. The manufacturing apparatus of FIG.
Sample via the first purified sample flow path 23 with 2
The tank 3 and the purification and concentration tank 5 is communicated, this point is different from that of FIG. But the others
It is substantially the same as that of FIG. Therefore, in the case of FIG.
In this case, the same members as those in FIG. 2 are designated by the same reference numerals.

【0024】図3の製造装置を用いた抽出工程はつぎの
ようなものである。記と様の前処理工程得られた
処理済サンプルS1抽出タンク1aにあるから、これ
有機酸を加えてコラーゲンを押出し、粗コラーゲン溶
液S1を得る。こうして得られた粗コラーゲン溶液S1
ポンプ2aでサンプルタンク3に投入する。さらに
2と同様、ポンプ3a・3bで流速などをコントロール
しながら精製膜4を通過させて第1精製コラーゲンS5
を精製・濃縮タンク5に流入させる。留物についても
前記と同様、サンプル循環流路6を介してサンプルタン
ク3に帰還させる。回収量を増やすため一定量の溶媒
溶媒添加用タンク7から溶媒添加流路8を通じてサン
プルタンク3へ加えたりする。精製・濃縮タンク5の第
1精製コラーゲン溶液S5については、ポンプ22を備
えた第1精製サンプル流路23を介してサンプルタンク
3へ戻し、ここでペプシンなどを加えることでアテロ化
処理を行う。かくてアテロ化されたもの次段の精製工
精製ろ過処理するが、当該実施態様では再度精製膜
4を介して繰り返しの精製を行い、これにより得られた
第2精製コラーゲン溶液S6精製・濃縮タンク5に流
入させる。以後は濃縮工程と滅菌ろ過工程を経ることで
前記同様第2ろ過滅菌後サンプルS7を回収する。
[0024] Extraction process using the manufacturing apparatus of Figure 3 is the following
Is like. Since the treated samples S1 obtained in the previous SL the same way the pre-process is Ru extraction tank 1a near, which
Adding an organic acid extruded City, collagen, crude collagen soluble
Liquid S1 is obtained. Crude collagen solution S1 thus obtained
Is charged into the sample tank 3 by the pump 2a. Further, as in FIG. 2, the first purified collagen S5 is passed through the purification membrane 4 while controlling the flow rate with the pumps 3a and 3b.
To the purification / concentration tank 5. For even the remaining Tomebutsu
Similar to the above, it is returned to the sample tank 3 via the sample circulation flow path 6 . A certain amount of solvent in order to increase the recovery amount
The or added to San <br/> Purutanku 3 through solvent addition channel 8 from the solvent added for the tank 7. A pump 22 is provided for the first purified collagen solution S5 in the purification / concentration tank 5.
Back through the first purified sample flow path 23 was example to support Npurutanku 3, wherein intends rows Atero process by adding such as pepsin. While you purified filtration in the next stage of the purification process of those Atero reduction in write, perform repeated purification via purified membrane 4 again in the embodiment, thereby the second purified collagen solution S6 was obtained Pour into the purification / concentration tank 5 . Thereafter recovering the second filter sterilized after sample S7 like the <br/> said at Rukoto through the concentration step with a sterile filtration step.

【0025】当該実施態様でも、抽出工程での精製膜を
膜サイズ1.0μm未満〜0.1μmに特定したり、
製工程の精製膜や濃縮工程の濃縮用膜を膜サイズ100
0K未満〜10Kに特定したりする。こうすることでコ
ラーゲ回収量確保色素など不純物の除去とを両立
させる。上記膜サイズの特定値をそれぞれ0.2μm〜
0.65μm、10K〜100Kにした場合はより望ま
しい結果られる。
Also in this embodiment, the purified membrane used in the extraction step is specified to have a membrane size of less than 1.0 μm to 0.1 μm, and the purified membrane used in the purification step or the concentration membrane used in the concentration step has a membrane size of 100.
It is specified to be less than 0K to 10K . Both the co <br/> Lage down recovery of ensuring the removal of impurities such as dyes That way
Let 0.2μm~ each particular value of said film size
When the thickness is 0.65 μm and 10K to 100K , more desirable results are obtained .

【0026】当該実施態様では、また、抽出工程の精製
通常のろ過膜を用いるが、精製工程の精製膜と濃縮
工程の濃縮用膜としてタンジェンシャル・フロー・フィ
ルトレーション(TFF)を用いることにより、不純物
除去作用の信頼性が持続する。
In this embodiment , an ordinary filtration membrane is used as the purification membrane in the extraction step, but tangential flow filtration (TFF) is used as the purification membrane in the purification step and the concentration membrane in the concentration step. As a result, the reliability of the impurity removing action is maintained.

【0027】[0027]

【発明の効果】本発明に係る海洋生物由来コラーゲンの
製造方法によるときはつぎのような効果が得られる。(1) 既存の 精製工程を廃し、精製ろ過処理による精製工
程についで濃縮工程を実施するようにしたので色素など
不純物の除去に際して高価設備が要らず、生産規模に応
じたコラーゲンの大量精製を実現することができる。こ
れは、また、コラーゲンに対する社会的な要請を充足で
きるということである。 (2) コラーゲン 製造日数を従来法に比べて大幅に短縮す
ることができる。ちなみに来の精製工程での遠心分離
塩析は2〜3回繰り返し実施され、これ10〜20
日を要していた。対する本発明での精製ろ過工程これ
続いて実施される濃縮工程1〜2日で終えることが
できる。 (3) 精製ろ過工程濃縮工程については、従来の遠心分
離や超遠心分離と異なり、閉鎖的な製造ラインを採用
ることができる外部汚染の心配がない。したがって
面からも安心してコラーゲンを製造することができ
る。 (4) 上記 両工程での精製膜濃縮用膜について各膜サイ
ズを特定することで、それぞれコラーゲ回収率と色
除去効率とが両立したり、望ましいコラーゲ回収率と
ペプシンなど不純物除去率とが両立したりする。これ
膜サイズの範囲を限定することで効果がさらに高ま
る。 (5) 精製膜濃縮用膜についてTFFを採用したことに
より、コラーゲンに係る最終製品の純度をより向上させ
ることができる。(6) 抽出工程で抽出とアテロ化と施していた
心分離処理を廃し、精製ろ過処理第1精製コラーゲン
溶液を得るようにしたから、これに続く精製工程と濃縮
工程以前の当該精製ろ過処理で、コラーゲンに対する不
純物の除去が行われる。したがって精製が行いやすくな
り、純度の高いコラーゲンの製造に益することとな
る。
The following effects can be obtained by the method for producing collagen derived from marine organisms according to the present invention. (1) Since the existing purification process is abolished and the concentration process is performed after the purification process by the purification filtration process, expensive equipment is not required for removing impurities such as pigments, and mass purification of collagen according to the production scale is realized. can do. This also means that it can meet the social demands for collagen . (2) base ratio to the conventional method collagen production dates can be greatly shortened. By the way, centrifugation at traditional purification process
And salting out is repeated 2-3 times, and 10-20
It took a day . In contrast to the purification filtration step in the present invention and this
The concentrating process that follows can be completed in 1-2 days.
it can. (3) for the purified filtration step and concentration steps, unlike the conventional centrifugation or ultracentrifugation, to adopt a closed production line
Worry of external contamination in the can Rukoto is not name. Therefore also it is possible to safely producing collagen from <br/> sanitation surface
It (4) By identifying each film size for purified membrane and concentrating film on the both steps, or both and the collagen recovery and color containing <br/> removal efficiency, respectively, the desired collagen recovery It is compatible with the removal rate of impurities such as pepsin . this
The effect is further enhanced by limiting the range of membrane size .
It (5) for the purified membrane and concentrating film that has been adopted the TFF
As a result, the purity of the final collagen product can be further improved. (6) abolished the far <br/> heart separation process have been made between the extraction and Atero of the extraction process, it is so arranged to obtain a first purified collagen solution with purified filtration, purification steps subsequent thereto and in the concentration step prior the purification filtration, Ru is performed the removal of impurities to collagen. Therefore, purification is easy
Ri, large door be Ekisuru in the production of high-purity collagen
It

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明方の一実施例を示した工程説明図[1] process explanatory view showing one embodiment of the present onset bright Way Method

【図2】図1の方法を実施するための製造装置を系統図
で略示した説明図
2 is a system diagram of a manufacturing apparatus for carrying out the method of FIG.
Explanatory diagram outlined in

【図3】本発明方法の他実施例をその製造装置の系統図
と共に略示した説明図
FIG. 3 is an explanatory view schematically showing another embodiment of the method of the present invention together with a system diagram of its manufacturing apparatus.

【図4】不純物除去のために汎用されている精製膜
用説明図
[4] created <br/> for illustration of purified membrane which is generally to remove impurities

【図5】本発明方法において不純物除去のために用いら
れるTFF(タンジェンシャル・フロー・フィルトレー
ション)の作用説明図
[5] The present invention is used for removing impurities in the process TFF (tangential flow fill trays
Of action)

【図6】ほ乳類の皮膚層を略示した縦断面図FIG. 6 is a longitudinal sectional view schematically showing the skin layer of mammals.

【図7】海洋生物の皮膚層を略示した縦断説明図FIG. 7 is a vertical cross sectional explanatory view schematically showing the skin layer of marine organisms.

【図8】従来の海洋生物由来コラーゲン製造方法を略示
した工程説明図
[8] of a conventional marine-derived collagen Manufacturing how shown schematically
The process illustration

【符号の説明】[Explanation of symbols]

4 精製膜 11 濃縮用膜 20 ろ過滅菌膜 S1 粗コラーゲン溶液 S2 精製コラーゲン溶液 S3 濃縮コラーゲン溶液 S4 滅菌ろ過後サンプル S5 第1精製コラーゲン溶液 S6 第2精製コラーゲン溶液 S7 滅菌ろ過後サンプル 4 Purification membrane 11 Concentrating membrane 20 Filtration sterilization membrane S1 crude collagen solution S2 purified collagen solution S3 concentrated collagen solution S4 Sample after sterile filtration S5 First purified collagen solution S6 Second purified collagen solution S7 Sterile filtered sample

フロントページの続き (56)参考文献 特開 平9−278639(JP,A) (58)調査した分野(Int.Cl.7,DB名) C07K 14/78 C07K 1/14 C07K 1/34 BIOSIS/CA/MEDLINE/W PIDS(STN)Continuation of the front page (56) Reference JP-A-9-278639 (JP, A) (58) Fields investigated (Int.Cl. 7 , DB name) C07K 14/78 C07K 1/14 C07K 1/34 BIOSIS / CA / MEDLINE / W PIDS (STN)

Claims (4)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】海洋生物の皮膚を脱脂した後これを洗浄し
て処理済サンプルを得る前処理工程と、この処理済サン
プルに有機酸を加えてコラーゲンを抽出するととも
れに蛋白質分解酵素を加えてアテロ化することにより粗
コラーゲン溶液を抽出する抽出工程と、この粗コラーゲ
ン溶液から不溶物を除去したものを精製膜で精製すると
き当該粗コラーゲン溶液がその流れ方向と直交する方向
に精製膜を透過していくようにする精製工程と、これに
より得られた精製コラーゲン溶液を濃縮用膜濃縮し
分子量分画以下の不純物を除去するとき当該精製コラー
ゲン溶液がその流れ方向と直交する方向に濃縮用膜を透
過していくようにする濃縮工程と、これにより得られた
濃縮コラーゲン溶液滅菌ガス加圧してろ過滅菌膜を
通過させる滅菌ろ過処理または当該濃縮コラーゲン溶液
を透析する透析処理のうち何れかを先行させてこれらの
処理を行うことにより滅菌ろ過後サンプルを回収する滅
菌ろ過工程とからなることを特徴とする海洋生物由来コ
ラーゲンの製造方法。
1. A This preprocessing step to obtain a washed and treated samples this was degreased skin marine organisms, to together when extracting collagen with an organic acid added to the treated sample
An extraction step of extracting the crude collagen solution by Atero by addition of proteolytic enzymes Les, purified that is obtained by removing the insoluble matter from the crude collagen solution with purified membranes
The direction in which the crude collagen solution is perpendicular to the flow direction
So that go through the purification membrane purification step and, the purified Koller when removing this by purified collagen solution concentrated membrane with concentrated by <br/> molecular weight fractionation following impurities obtained
The gen solution passes through the concentration membrane in a direction orthogonal to its flow direction.
A concentration step to go spent, sterile filtration or the concentrate collagen solution is passed through a sterile filtration membrane thus obtained was concentrated collagen solution is pressurized with sterile gas
These are preceded by any of the dialysis treatments
A method for producing collagen derived from marine organisms, which comprises a sterilization filtration step of recovering a sample after sterilization filtration by performing a treatment .
【請求項2】海洋生物の皮膚を脱脂した後これを洗浄し
て処理済サンプルを得る前処理工程と、この処理済サン
プルに有機酸を加えてコラーゲンを抽出した粗コラーゲ
ン溶液から不溶物を除去したりそれを精製膜して
製ろ過したりさらにそれに蛋白質分解酵素を加えてアテ
ロ化したりする抽出工程と、これにより得られた第1精
製コラーゲン溶液を精製膜で精製するとき当該第1精製
コラーゲン溶液がその流れ方向と直交する方向に精製膜
を透過していくようにする精製工程と、これにより得ら
れた第2精製コラーゲン溶液を濃縮用膜で濃縮して分子
量分画以下の不純物を除去するとき第2精製コラーゲン
溶液がその流れ方向と直交する方向に濃縮用膜を透過し
ていくようにする濃縮工程と、これにより得られた濃縮
コラーゲン溶液滅菌ガス加圧してろ過滅菌膜を通過
させる滅菌ろ過処理または当該濃縮コラーゲン溶液を透
析する透析処理のうち何れかを先行させてこれらの処理
を行うことにより滅菌ろ過後サンプルを回収する滅菌ろ
過工程とからなることを特徴とする海洋生物由来コラー
ゲンの製造方法。
2. A pretreatment step of degreasing the skin of marine organisms and then washing this to obtain a treated sample, and removing insoluble matter from a crude collagen solution obtained by adding collagen to the treated sample to extract collagen. in or the extraction step or to Atero by addition of the passing to fine <br/> made filtered or more proteolytic enzyme to it in purified membrane thereto, purified membrane first purified collagen solution thereby obtained When refining the first purification
Purification membrane with collagen solution in a direction orthogonal to its flow direction
A purification step to make go through the second purification collagen When this second purification collagen solution obtained by the concentrated in concentrating film removing molecular <br/> weight fraction following impurities
The solution permeates through the concentrating membrane in a direction orthogonal to its flow direction.
A concentration step in going way, thereby sterilizing filtration process or the concentrate collagen solution to the concentrated collagen solution is passed through a pressurized filter sterilized membrane sterile gas obtained translucency
These treatments are preceded by any of the dialysis treatments
The method for producing collagen derived from marine organisms, which comprises performing a sterilizing filtration to recover a sample by performing a sterilizing filtration.
【請求項3】精製工程における精製膜が膜サイズ1.0
μm未満〜0.1μmのものであり、濃縮工程における
濃縮用膜が膜サイズ1000K未満〜10Kの限外ろ過
である請求項1または2記載の海洋生物由来コラーゲ
ンの製造方法。
3. The purified membrane in the purification step has a membrane size of 1.0.
The method for producing collagen derived from marine organisms according to claim 1 or 2 , wherein the concentration membrane in the concentration step is an ultrafiltration membrane having a membrane size of less than 1000K-10K.
【請求項4】精製工程における精製膜が膜サイズ0.2
μm〜0.65μmのものであり、濃縮工程における
縮用膜が膜サイズ10K〜100Kのものである請求項
1〜3いずれかに記載の海洋生物由来コラーゲンの製造
方法。
4. The purified membrane used in the purification step has a membrane size of 0.2.
μm~0.65μm are of Claim concentrated <br/> reduced membrane in the concentration step is of film size 10K~100K
The method for producing collagen derived from marine organisms according to any one of 1 to 3 .
JP2000014283A 2000-01-24 2000-01-24 Method for producing marine organism-derived collagen Expired - Lifetime JP3532817B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000014283A JP3532817B2 (en) 2000-01-24 2000-01-24 Method for producing marine organism-derived collagen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000014283A JP3532817B2 (en) 2000-01-24 2000-01-24 Method for producing marine organism-derived collagen

Publications (2)

Publication Number Publication Date
JP2001200000A JP2001200000A (en) 2001-07-24
JP3532817B2 true JP3532817B2 (en) 2004-05-31

Family

ID=18541761

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000014283A Expired - Lifetime JP3532817B2 (en) 2000-01-24 2000-01-24 Method for producing marine organism-derived collagen

Country Status (1)

Country Link
JP (1) JP3532817B2 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919306B2 (en) 1999-08-09 2005-07-19 Yaizu Suisankagaku Industry Co. Ltd. Method of skin care
JP2003180820A (en) * 2001-10-09 2003-07-02 Techno Network Shikoku Co Ltd Biological material, drug, food, medical instrument, cell culture instrument and process of producing tissue- inducible material
KR100492371B1 (en) * 2002-05-01 2005-05-30 주식회사 부원바이오텍 Method for manufacturing mild water-soluble collagen
JP2005087440A (en) 2003-09-17 2005-04-07 Matsumoto Shika Univ Composition containing raw material of marine organism and production method of the composition
JP2005095331A (en) * 2003-09-24 2005-04-14 Ihara Suisan Kk Foamed body sheet containing fishskin dermal collagen and its use
US7795010B2 (en) 2004-01-21 2010-09-14 Toray Industries, Inc. Fractionator and method of fractionation
JP2005232156A (en) * 2004-01-21 2005-09-02 Toray Ind Inc Solution of purified component of living body,method for separating the component of the living body and apparatus for separating the component of the living body
DE102005008416B4 (en) * 2005-02-24 2011-09-29 Lohmann & Rauscher Gmbh & Co. Kg Process for the purification of marine collagen
JP2007022958A (en) * 2005-07-15 2007-02-01 Katakura Chikkarin Co Ltd Atelocollagen and/or its derivative derived from squid or catfish, method for producing the same, and cosmetic compounded of the atelocollagen and/or its derivative
JP2007166989A (en) * 2005-12-22 2007-07-05 Sanki Shiro Kogyo Kk Method for treating bony part of fish
JP2007211053A (en) * 2006-02-07 2007-08-23 Miyagi Prefecture Blue dye, blue collagen or gelatin and method for producing those
HUE038789T2 (en) * 2009-10-07 2018-11-28 Kerecis Ehf A scaffold material for wound care and/or other tissue healing applications
JP5937786B2 (en) * 2011-03-29 2016-06-22 片倉コープアグリ株式会社 Marine organism-derived collagen containing type III collagen and derivatives thereof
CN102260727A (en) * 2011-06-24 2011-11-30 申铉日 Preparation method of low-molecule aquatic collagen peptide
JP6090823B2 (en) * 2012-05-25 2017-03-08 国立大学法人東京工業大学 Method for extracting collagen and method for producing collagen
JP6145630B2 (en) * 2012-11-28 2017-06-14 地方独立行政法人青森県産業技術センター Protein rich in glycine
KR101576060B1 (en) * 2013-09-02 2015-12-10 세원셀론텍(주) A High Concentration Collagen and method of preparing
KR101531479B1 (en) 2014-11-21 2015-06-26 세원셀론텍(주) High concentration collagen production method for use as medical materials
JP6666078B2 (en) * 2015-05-15 2020-03-13 花王株式会社 Immersion cleaning composition for tableware and cleaning method
CN107428800B (en) 2015-07-08 2020-11-27 中国食品发酵工业研究院 Active peptide for inhibiting AMPA receptor and preparation method and application thereof
CN105348383A (en) * 2015-12-15 2016-02-24 中国海洋大学 Odourless fishskin collagen and preparation method thereof
JP6265350B2 (en) * 2016-06-03 2018-01-24 有限会社松下海産 Extraction method of collagen and gelatin
KR101760890B1 (en) 2016-07-13 2017-07-24 투윈파마 주식회사 Preparing method of Collagen
CN110564796A (en) * 2019-07-13 2019-12-13 德州蓝力生物技术有限公司 Production process of hydrolyzed collagen
CN115028707A (en) * 2022-07-05 2022-09-09 福建爱洁丽日化有限公司 Large yellow croaker skin collagen and preparation method and application thereof

Also Published As

Publication number Publication date
JP2001200000A (en) 2001-07-24

Similar Documents

Publication Publication Date Title
JP3532817B2 (en) Method for producing marine organism-derived collagen
Porter et al. Utrafiltration in the Chemical, Food Processing, Pharmaceutical, and Medical Industries
US4623723A (en) Process for separating ribonucleic acids from a solution containing deoxyribonucleic acids
JPH0466455B2 (en)
CN212476724U (en) Instrument for rapidly extracting and separating stem cell exosomes
CN109021096A (en) A kind of separation and Extraction purifying process of spirulina polysaccharide and phycocyanin
CN102961741B (en) Method for preparing tetanus toxoid vaccine
CN1204148C (en) Separation and purification process of lentinan
CN113388575A (en) Preparation method of mesenchymal stem cell exosome for skin injury repair
CN101333245B (en) Method for separating human serum albumin
CN106699838A (en) Method for preparation of active protein peptide lyophilized powder from animal fetuses and placentas thereof
CN102961740A (en) Preparation method of diphtheria toxoid vaccine
CN106366200A (en) Method for preparing recombinant staphylokinase-hirudin fusion protein
CN107129530A (en) A kind of extracting method of bursopoietin
CN113197920A (en) Preparation method of embryonic stem cell culture extract for skin aging resistance
EP4349958A1 (en) Isolation and purification method of extracellular vesicles
CN104725466A (en) Method for extracting earthworm active protein for cosmetics
CN114471163A (en) Ultrafiltration device and method for purifying and concentrating exosome by secondary two-stage tangential flow separation
CN111019882A (en) Separation and purification method of skin epidermal stem cell exosomes
CN116421708B (en) Extraction of ovalbumin from pigeon egg white and application of ovalbumin in wound repair
JP3371783B2 (en) Cell isolation method
CN108977423A (en) A method of the separating-purifying angiotensin converting enzyme from pig lung
CN216604777U (en) Ultrafiltration device for secondary two-stage tangential flow separation purification and concentration of exosomes
JP2002112800A (en) Apparatus for refining starch saccharified liquor
JP3880036B2 (en) Protein concentration method

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20031224

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20040210

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20040304

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 3532817

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080312

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090312

Year of fee payment: 5

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090312

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100312

Year of fee payment: 6

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100312

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110312

Year of fee payment: 7

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110312

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120312

Year of fee payment: 8

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120312

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130312

Year of fee payment: 9

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130312

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140312

Year of fee payment: 10

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term